Ki-67 and CD34 were used as one of the markers in their scoring scale. Ki-67 was performed in all patients and CD34 expression was added if coagulative tumor cell necrosis was observed. All ULMS samples had Ki-67 labeling index was 15% or more. Here, CD34 is linked to neoplasm.